hirudoid

No local reactions as result of the treatment with Hirudoid were observed .

未观察到因应用喜疗妥治疗而引起的局部反应。

A Study on Treatment Using Hirudoid Cream for Leakage of Irritating Drug Infusion

喜疗妥药膏治疗刺激性药物输注渗漏的效果观察

Thus , Hirudoid showed to have an equivalent efficacy and safety to the approved preparation .

因此，喜疗妥的有效性和安全性与这一被认可的制剂相同。

Clinical observation of the therapeutic effect of hirudoid on the deep 2nd degree burn wound at the early stage

深Ⅱ°烧伤创面早期应用类肝素药物的临床观察

Hirudoid / Hirudoid forte inhibit enzymes that cause tissue degeneration .

喜疗妥乳膏/强喜疗妥乳膏能抑制导致组织分解代谢的酶。

Hirudoid forte stimulates the production of proteoglycans and thereby promote tissue regeneration .

特强喜疗妥乳膏能刺激蛋白多糖的生成，因而能促进组织再生。

The more rapid regression of thrombosis under treatment with Hirudoid was associated with an accelerated relief of symptoms .

用喜疗妥治疗后，血栓衰退更迅速，这是与症状的加速改善相对应的。

The tolerability of Hirudoid forte cream and gel was equally good .

特强喜疗妥软膏和凝胶耐受性都相当好。

Using an identical study design , the same author compared the effect of Hirudoid gel to placebo and to the untreated control group .

应用同样的研究设计，该作者还以未治疗的对照组和安慰剂为对比，观测了特强喜疗妥凝胶的作用。

Conclusion Diprospan And hirudoid was better than only use diprospan on treatment of keloid .

结论：得宝松局部封闭加喜疗妥外用治疗瘢痕疙瘩可起到满意疗效。

Study on diprospan and hirudoid treatment of keloid

复方倍他米松注射液加喜疗妥治疗瘢痕疙瘩疗效观察

Therapy with Hirudoid and Hirudoid forte is without systemic adverse reactions and without influence on systemic coagulation .

用喜疗妥和特强喜疗妥治疗，没有全身副作用，不影响凝血系统。

The excellent tolerability of Hirudoid and Hirudoid forte is therefore of particular importance .

喜疗妥和特强喜疗妥由于其极好的耐受性而特别重要。

The efficacy of Hirudoid was verified in particular in those patients who had had operations at both legs during one session .

特别是对于那些双腿同时接受手术的患者，喜疗妥的疗效得到了进一步验证。

Hirudoid forte have an excellent local and systemic tolerability , no influence on blood coagulation has been observed .

特强喜疗妥乳膏具有极好的局部和系统耐受性，不影响机体血凝系统。

There was a significant faster dissolution of haematomas under the treatment with Hirudoid in comparison to placebo .

血肿的分解，喜疗妥组要显著快于安慰剂组。

The faster elimination of radioactivity under treatment with Hirudoid forte corresponded with an earlier relief of clinical symptoms .

用特强喜疗妥治疗后伴随着放射活性的快速消退是临床症状的更早缓解。

The haematoma on one side was treated with Hirudoid cream and that of the contralateral side with placebo .

一侧的血肿用喜疗妥软膏治疗，对侧则用安慰剂。

The simple and safe therapy with Hirudoid was stressed in particular ; symptoms of irritation were not observed in any of the cases .

研究者特别强调了用喜疗妥治疗方便、安全，未在任何病例观察到有刺激症状。

One ear was treated with Hirudoid cream , while the other ear was either left untreated or treated with the cream base only .

一只耳朵用喜疗妥软膏治疗，而另一只耳朵则不治疗或只用软膏基质治疗。

The results show a significantly faster absorption of haematomas treated with Hirudoid cream compared with placebo-treated and totally untreated controls .

实验结果显示，血肿的吸收喜疗妥组比安慰剂组和完全不治疗组要快得多。

Hirudoid and Hirudoid forte have excellent skin tolerability .

喜疗妥和喜疗妥特强软膏有极佳的皮肤耐受性。

Alter used Hirudoid gel for the treatment of188 patients suffering from varicosities , haematomas and acute phlebitis .

Alter应用喜疗妥凝胶治疗了共188位静脉曲张、血肿和急性静脉炎患者。

When compared to the reference group , treated with cream base , a clear shortening of the mean thrombus length was seen after the administration of hirudoid .

而与用软膏基质的对照组相比，应用喜疗妥后平均血栓长度明显缩短。

After topical application of Hirudoid and Hirudoid forte plasma levels of MPS are Iow and no influence on blood coagulation can be determined .

外用喜疗妥和特强喜疗妥软膏后，MPS血浆水平很低并且不影响凝血系统。

The investigating physicians assessed the skin tolerability of Hirudoid and Hirudoid forte as good or very good in 97,3 % of all cases .

调查医师对喜疗妥或特强喜疗妥的皮肤耐受性评价为好或非常好的病例百分比为97.3%。

Within the one week therapy with Hirudoid the inflammatory signs in all patients had either completely subsided or had improved to such an extent that a complete healing was achieved .

在用喜疗妥治疗的一周期间，所用患者的炎症均显著减轻或痊愈了。

Several placebo-controlled studies in this indication provide objective evidence that topically applied Hirudoid and Hirudoid forte accelerate the regression of superficial thrombi and inflammation .

几项安慰剂对照的临床研究，将喜疗妥和喜疗妥特强乳膏外用于输注性血栓性静脉炎，客观地论证了其能有效地治疗浅表血栓和炎症。

The experience gained with Hirudoid and Hirudoid forte in general and clinical practice during several decades has been documented in an extensive number of publications and reports .

大量的出版物及报道记载了喜疗妥和特强喜疗妥软膏数十年来在专科和全科应用中的经验。

A similar placebo-controlled double-blind study was performed with Hirudoid forte in40 patients with infusion thrombophlebitis ( Schedel et al . ) .

Schedel等人进行了一项相似的安慰剂对照双盲临床研究，用特强喜疗妥乳膏治疗40位输注性血栓性静脉炎患者。